'Status Quo' Interim Pricing Guidance Now In Force In Canada
Provisional guidance on controversial pricing reforms is now in place in Canada.
You may also be interested in...
The implementation of new pricing guidelines that are unpopular with the pharmaceutical has been put on hold, to the relief of the pharmaceutical industry.
New draft guidelines outlining how Canada’s drug pricing authority will decide whether to investigate if a medicine is excessively priced are now out for consultation.
Changes to Canada’s reference pricing system kick in on 1 July and could save billions.